
Want to inform investors similar to EMPATHIQ about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest EMPATHIQ News
Sep 23, 2019
– EMPATHIQ acquires Rivews, a patient experience and reputation platform that enables healthcare organizations in instantly connecting with patients via text-message post-care. – The acquisition will enable EMPATHIQ to further advance from its current online reporting and monitoring platform to enabling healthcare organizations in the collection of real-time patient feedback and surveys after-care. – To date, Rivews has identified over 32,500 patient complaints with 17,500 of them including thorough and lengthy insight of additional comments sent by patients. EMPATHIQ , a software company that provides review management and patient experience software for health providers, today announced it has acquired Rivews , an NYC-based company that provides healthcare organizations with a text-message platform that enables them to instantly survey patients after-care. The company, also a StartUp Health portfolio company, has been entirely bootstrapped and has partnerships with leading EHRs including athenahealth and eMDTec. Financial details of the acquisition were not disclosed. Transforming Brand Reputationthrough Patient Engagement Founded in 2016, Rivews was launched with the mission of assisting healthcare organizations to manage, build and protect every aspect of reputation, from patient satisfaction to online reputation to patient retention. , The patient experience and reputation platform enable healthcare organizations in instantly connecting with patients via text-message post-care. With nearly 1 in 3 patientsengaging with Rivews’ feedback management system, Rivews has engaged with over1.8 million patients, with an average response rate of 28%. To date, Rivews hasidentified over 32,500 patient complaints with 17,500 of them includingthorough and lengthy insight of additional comments sent by patients. The datahas enabled Rivews to identify real-time patient satisfaction scores to betterunderstand patient experiences by locations, providers, case and other metrics. RivewsAcquisition Helps EMPATHIQ Establish Advance Patient Experience & SurveyPlatform EMPATHIQ helps individual health providers, hospitals, and health systems monitor and optimize their online reviews across 70+ health review sites. Using valuable review data, health providers and organizations can understand how and where to improve the patient experience. The acquisition will enable EMPATHIQ to further advance from its current online reporting and monitoring platform to enabling healthcare organizations in the collection of real-time patient feedback and surveys after-care. The acquisition will also strengthen and give EMPATHIQ major advantage and leverage as it molds into a full-fledged patient experience software company. “We’re proud of how far we’ve come, especially considering we’ve entirely bootstrapped this company over the course of the past three years. This acquisition will enable both parties in addressing one of the most important bottomline components of healthcare, patient experience and outcomes,” said Yasir Ali, co-founder and CEO. “We’ve seen a proliferation of phenomenal patient engagement solutions over the years improving patient experience and satisfaction, yet, we believe, only a very minuscule number actually address the collection of data on these patient experiences. Without real-time data, healthcare organizations are guessing how their patients actually feel. And because the vastly utilized survey platforms in the healthcare market, ranging from paper to email surveys, are very antiquated and lack data, we genuinely believe there’s a huge opportunity here. There’s a lot under the hood that we’re keeping in stealth-mode as both companies merge.”
EMPATHIQ Acquisitions
1 Acquisition
EMPATHIQ acquired 1 company. Their latest acquisition was Rivews on September 23, 2019.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
9/23/2019 | Seed / Angel | Acquired | 1 |
Date | 9/23/2019 |
---|---|
Investment Stage | Seed / Angel |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired |
Sources | 1 |